Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID12891 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12892 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12893 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12894 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12895 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12896 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12897 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12898 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12899 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12900 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12901 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12902 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12903 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12904 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12905 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12906 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12907 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12908 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Downregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12909 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12910 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12911 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12912 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12913 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID12914 | NA | NA | Serum | NA | MALDI-TOF | Breast cancer | Upregulated in breast cancer patients vs healthy | 22521044 |
| CancerPDF_ID14333 | NA | NA | Serum | 622.48 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14334 | NA | NA | Serum | 622.97 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14335 | NA | NA | Serum | 654.73 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14336 | NA | NA | Serum | 655.23 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14337 | NA | NA | Serum | 666.78 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14338 | NA | NA | Serum | 667.12 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14339 | NA | NA | Serum | 676.83 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14340 | NA | NA | Serum | 698.4 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14341 | NA | NA | Serum | 698.81 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14342 | NA | NA | Serum | 720.8 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14343 | NA | NA | Serum | 721.4 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14344 | NA | NA | Serum | 858.11 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14345 | NA | NA | Serum | 887.23 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14346 | NA | NA | Serum | 893.99 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14347 | NA | NA | Serum | 909.06 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14348 | NA | NA | Serum | 909.75 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14349 | NA | NA | Serum | 1618.46 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14350 | NA | NA | Serum | 1866.64 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14351 | NA | NA | Serum | 2770.34 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14352 | NA | NA | Serum | 2771.86 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14353 | NA | NA | Serum | 2933.97 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14354 | NA | NA | Serum | 5963.91 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14355 | NA | NA | Serum | 7772.04 | IMAC-MB | Breast cancer | NA | 22521044 |
| CancerPDF_ID14356 | NA | NA | Serum | 7777.16 | IMAC-MB | Breast cancer | NA | 22521044 |